UK watchdog opens probe into Greencore-Bakkavor merger

The UK's Competition and Markets Authority (CMA) has launched an initial probe into Greencore Group Plc's proposed £1.2 billion acquisition of Bakkavor Group Plc, a deal that would merge two of the UK's largest convenience and chilled food suppliers. This first-stage investigation, set to conclude by October 27, will assess potential competition reduction in the UK grocery supply chain. The combined entity is projected to generate £4 billion in annual revenues and achieve £80 million in annual pre-tax cost savings by year three, with Greencore shareholders holding approximately 56% of the merged group.

Analysis

The UK's Competition and Markets Authority (CMA) has initiated a first-stage investigation into Greencore Group's (GNC) proposed £1.2 billion acquisition of Bakkavor Group (BAKK), introducing significant regulatory uncertainty to the deal. The merger would create a dominant force in the UK convenience food market with combined annual revenues of approximately £4 billion. The negative sentiment score for Greencore (-0.2) reflects the risks associated with the acquisition, including the CMA probe and the £90 million in estimated costs to achieve a projected £80 million in annual pre-tax synergies by year three. Conversely, Bakkavor's positive sentiment score (0.4) is aligned with its shareholders receiving a premium valuation of 200 pence per share, comprising cash and Greencore equity. The CMA's review, set to conclude by October 27, will be the pivotal event, determining whether the merger proceeds or is referred for a more intensive Phase 2 investigation due to concerns about reduced competition in the grocery supply chain. While the companies argue for synergy benefits across manufacturing and procurement, the primary focus for investors remains the regulatory hurdle, which overshadows the operational and financial logic of the combination.

Key Decisions for Investors

• Investors should closely monitor the UK Competition and Markets Authority's review, as a decision to refer the deal to a Phase 2 investigation by the October 27 deadline would be a significant negative catalyst for both stocks.
• For Greencore (GNC) investors, the regulatory overhang and integration costs warrant a cautious stance; the outcome of the CMA review is the primary driver of near-term value.
• Bakkavor (BAKK) shareholders are positioned to receive a deal premium, but the stock's value is now heavily tied to the probability of the acquisition's approval and is sensitive to any adverse regulatory news.